Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow margin | 18.7% | 20.1% | 17.4% | 15.6% | 17.5% | 21.0% | 23.0% | 20.1% | 18.9% | 16.0% | 19.0% | 16.0% | 17.4% | 19.7% | 20.5% | 23.4% | 22.2% | 22.9% | 22.3% | 25.1% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 25.4%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Free Cash Flow margin for Novartis AG have been 22.7% over the past three years, and 24.0% over the past five years.
As of today, Novartis AG's Free Cash Flow margin is 25.4%, which is higher than industry median of 19.1%. It indicates that Novartis AG's Free Cash Flow margin is Good.